Literature DB >> 10022807

Phenotypic analysis of human glioma cells expressing the MMAC1 tumor suppressor phosphatase.

A M Morimoto1, A E Berson, G H Fujii, D H Teng, S V Tavtigian, R Bookstein, P A Steck, J B Bolen.   

Abstract

MMAC1, also known as PTEN or TEP-1, was recently identified as a gene commonly mutated in a variety of human neoplasias. Sequence analysis revealed that MMAC1 harbored sequences similar to those found in several protein phosphatases. Subsequent studies demonstrated that MMAC1 possessed in vitro enzymatic activity similar to that exhibited by dual specificity phosphatases. To characterize the potential cellular functions of MMAC1, we expressed wild-type and several mutant variants of MMAC1 in the human glioma cell line, U373, that lacks endogenous expression. While expression of wild-type MMAC1 in these cells significantly reduced their growth rate and saturation density, expression of enzymatically inactive MMAC1 significantly enhanced growth in soft agar. Our observations indicate that while wild-type MMAC1 exhibits activities compatible with its proposed role as a tumor suppressor, cellular expression of MMAC1 containing mutations in the catalytic domain may yield protein products that enhance transformation characteristics.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10022807     DOI: 10.1038/sj.onc.1202441

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

1.  Phosphatase and tensin homolog on chromosome 10 is phosphorylated in primary effusion lymphoma and Kaposi's sarcoma.

Authors:  Debasmita Roy; Dirk P Dittmer
Journal:  Am J Pathol       Date:  2011-08-03       Impact factor: 4.307

2.  Transcriptional activation of p21WAF1 by PTEN/MMAC1 tumor suppressor.

Authors:  R C Wu; X Li; A H Schönthal
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

3.  Analysis of the cellular functions of PTEN using catalytic domain and C-terminal mutations: differential effects of C-terminal deletion on signalling pathways downstream of phosphoinositide 3-kinase.

Authors:  N R Leslie; A Gray; I Pass; E A Orchiston; C P Downes
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

4.  Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2.

Authors:  X Wu; K Hepner; S Castelino-Prabhu; D Do; M B Kaye; X J Yuan; J Wood; C Ross; C L Sawyers; Y E Whang
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

5.  Protein tyrosine phosphatase RQ is a phosphatidylinositol phosphatase that can regulate cell survival and proliferation.

Authors:  A Oganesian; M Poot; G Daum; S A Coats; M B Wright; R A Seifert; D F Bowen-Pope
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-11       Impact factor: 11.205

6.  Involvement of Akt/NF-κB pathway in antitumor effects of parthenolide on glioblastoma cells in vitro and in vivo.

Authors:  Hiromichi Nakabayashi; Keiji Shimizu
Journal:  BMC Cancer       Date:  2012-10-05       Impact factor: 4.430

7.  PTEN/MMAC1 expression in melanoma resection specimens.

Authors:  M Deichmann; M Thome; A Benner; U Egner; W Hartschuh; H Näher
Journal:  Br J Cancer       Date:  2002-12-02       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.